[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100552828":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":29,"centralContacts":33,"locations":40,"responsibleParty":79,"collaborators":82,"id":90,"slug":91,"hasResults":92,"nctId":93,"briefTitle":94,"officialTitle":95,"acronym":25,"eligibilityCriteria":96,"healthyVolunteers":92,"sex":97,"minAge":98,"maxAge":25,"enrollmentInfo":99,"targetDuration":25,"studyType":102,"phases":103,"briefSummary":105,"conditions":106,"keywords":108,"overallStatus":56,"whyStopped":25,"lastUpdateSubmitDate":126,"lastUpdatePostDateStruct":127,"startDateStruct":130,"completionDateStruct":132,"leadSponsor":134,"locationsCount":135},{"fullName":5,"class":6},"University of Barcelona","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"CBSD-experimental group","EXPERIMENTAL","blood collection with Closed-Blood Sampling System (CBSD)",[13],"Device: Closed-Blood Sampling Devices",{"label":15,"type":16,"description":17,"interventionNames":18},"Waste discard volume, control group","ACTIVE_COMPARATOR","Blood collection without CBSD, usual practice, need to waste discard volume",[19],"Other: Waste discard volume",[21,26],{"type":22,"name":23,"description":11,"armGroupLabels":24,"otherNames":25},"DEVICE","Closed-Blood Sampling Devices",[9],null,{"type":6,"name":27,"description":17,"armGroupLabels":28,"otherNames":25},"Waste discard volume",[15],[30],{"name":31,"affiliation":5,"role":32},"Raurell-Torreda Marta","PRINCIPAL_INVESTIGATOR",[34],{"name":35,"role":36,"phone":37,"phoneExt":38,"email":39},"Raurell-Torreda Marta, PhD","CONTACT","626154955","0034","mraurell@ub.edu",[41,54,65],{"facility":42,"status":43,"city":44,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":25},"Hospital Universitario 12 de Octubre","COMPLETED","Madrid","28041","Spain","ES",{"type":49,"coordinates":50},"Point",[51,52],-3.70256,40.4165,{"lat":52,"lon":51},{"facility":55,"status":56,"city":44,"state":44,"zip":25,"country":46,"countryCode":47,"cosmosGeoPoint":57,"geoPoint":59,"contacts":60},"Hospital Rey Juan Carlos","RECRUITING",{"type":49,"coordinates":58},[51,52],{"lat":52,"lon":51},[61],{"name":62,"role":36,"phone":63,"phoneExt":25,"email":64},"Lopez S Cuenca, MD, PhD","34678288416","sonia.lopez@hospitalreyjuancarlos.es",{"facility":66,"status":56,"city":67,"state":68,"zip":25,"country":46,"countryCode":47,"cosmosGeoPoint":69,"geoPoint":73,"contacts":74},"Hospital Virgen de la Macarena","Seville","Sevilla",{"type":49,"coordinates":70},[71,72],-5.97317,37.38283,{"lat":72,"lon":71},[75],{"name":76,"role":36,"phone":77,"phoneExt":25,"email":78},"Fernandez R Castillo, RN, PhD","34679080810","rfernandezc@us.es",{"type":32,"investigatorFullName":80,"investigatorTitle":81,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Marta Raurell-Torreda","Clinical Professor",[83,84,86,88],{"name":42,"class":6},{"name":85,"class":6},"Hospital Universitario Rey Juan Carlos",{"name":87,"class":6},"Hospital General Universitario Gregorio Marañon",{"name":89,"class":6},"Hospital Universitario Virgen Macarena","100552828","closed-blood-sampling-devices-in-the-adult-critically-ill-patient-100552828",false,"NCT06478160","Closed-blood Sampling Devices in the Adult Critically Ill Patient","Effectiveness of Closed-blood Sampling Devices in the Adult Critically Ill Patient: Multicenter Randomized Clinical Trial","Inclusion Criteria:\n\n* Adult patients with an arterial catheter who agree to participate in the study, with a stay in the ICU of 24h and a minimum of 72h more with an arterial catheter\n\nNon-inclusion criteria: Therapeutic Limitation of Life Support, Jehovah's Witnesses.\n\nExclusion Criteria:\n\n* Patients with chronic renal failure\n* Patients with active gastrointestinal bleeding\n* Patients diagnosed with hematologic cancer\n* Women with menstruation at the time of admission\n* Pregnant women\n\nWithdrawal criteria: presence of active gastrointestinal bleeding during the study inclusion period.","ALL","18 Years",{"count":100,"type":101},216,"ESTIMATED","INTERVENTIONAL",[104],"NA","Based on the hypothesis that the strategy of using Closed-Blood Sampling Devices (CSBD, experimental group) compared to the usual practice (waste discard volume, control group), in critically ill adult patients, will decrease the amount of blood withdrawn for laboratory tests, we want to analyze the number of red blood cells (RBC) administered and arterial catheter-related adverse events (catheter-related bacteremia, catheter obstruction, CBSD malfunction, loss of arterial pressure waveform on the patient's bedside monitor) in both study groups, during ICU stay and up to a maximum of 21 days.",[107],"Acceptability of Health Care",[109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125],"anaemia","transfusion","diagnostic blood loss","phlebotomy","blood management","hospital-acquired anemia","iatrogenic anemia","sampling practices","blood conservation","blood sample collection","catheter-related infections","critical care","nursing","blood conservation devices","clinical trial","laboratory testing","blood chemistry tests","2025-11-06",{"date":128,"type":129},"2025-11-10","ACTUAL",{"date":131,"type":129},"2024-11-11",{"date":133,"type":101},"2026-06-07",{"name":5,"class":6},3]